Patient characteristics | Cervical cancer | Pre-cancerous | Benign lesion | Total | Chi2 | P-value | Multinomial logistic regression | |
---|---|---|---|---|---|---|---|---|
n (%) | n (%) | n (%) | R (95%CI) | P-value | ||||
HIV status | ||||||||
HIV positive | 14 (53.9) | 61 (61.0) | 79 (38.9) | 154 | 13.684 | 0.001 | 2.1[1.28–3.51] | 0.004 |
HIV negative | 12 (46.2) | 39 (39.0) | 124 (61.1) | 175 | ||||
Parity | ||||||||
Nulliparous | 2 (7.7) | 6 (6.0) | 6 (2.9) | 14 | -* | 0.311 | – | – |
Para1-4 | 13 (50.0 | 64 (64.0) | 126 (62.1) | 203 | ||||
Para ≥ 5 | 11 (42.3 | 30 (30.0) | 71 (34.9) | 112 | ||||
Age | ||||||||
21–30 | 3 (11.5) | 13 (13.0) | 28 (13.8) | 44 | 2.2 [0.62–7.83] | 0.220 | ||
31–40 | 9 (34.6) | 52 (52.0) | 66 (32.5) | 127 | 3.3[1.04–10.37] | 0.042 | ||
41–50 | 11 (42.3) | 31 (31.0) | 87 (42.9) | 129 | -* | 0.035 | 1.7 [0.52–5.31] | 0.383 |
≥51 | 3 (11.5) | 4 (4.0) | 22 (10.8) | 29 | – | – | ||
Type of visit | ||||||||
First visit for VIA | 7 (5.6) | 30 (24.0) | 88 (70.4) | 125 | ||||
First follow-up a year after treatment with CRYO/LEEP | 2 (7.7) | 12 (46.2) | 12 (46.2) | 26 | ||||
A follow-up visit after VIA negative | 3 (7.9) | 11 (29.0) | 24 (63.2) | 38 | -* | 0.167 | – | – |
Client with VIA positive referred for CRYO/LEEP | 14 (10.) | 47 (33.6) | 79 (56.4) | 140 | ||||
LEEP treatment provider | ||||||||
Medical officer | 21 (80.8) | 65 (65.0) | 153 (75.4) | 239 | –* | 0.102 | – | – |
Gynecologist | 10 (8.9) | 37 (32.7) | 66 (58.4) |